Genetic Technologies (ASX:GTG)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Genetic Technologies.
RELATED STOCKHEAD STORIES
Health Check: The robots are taking over biotech stock selection
Rise and Shine: Everything you need to know before the ASX opens
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
ASX Health Stocks: GTG pivots to US, vows to build a more efficient business
ASX Health Stocks: GTG’s GeneType Test can identify 80pc of people with risk of serious disease
Top 10 at 11: This morning is all about techies and goldies and bears, oh my!
ASX Health Stocks: Cleo up 30pc and GTG up 13pc after cancer test kit progress
Top 10 at 10: REE-nergised rare earths explorers, biotech standouts lead Wednesday’s winners
ASX Health Stocks: GTG to establish pilot program in US using its geneType Breast Cancer Risk Test
ASX Small Caps and IPO Weekly Wrap: Does anyone else want to pretend this week didn’t happen?
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: Lessons aplenty as ASX dives on Day 2, while lithium upstart Wildcat Resources takes +2796pc out of 2023
